Yüklüyor......
Efalizumab in the treatment of psoriasis
The humanized antibody efalizumab is currently the only T-cell directed biologic approved for the treatment of moderate-to-severe psoriasis by both American and European authorities. Binding to and blocking the function of the adhesion molecule leukocyte function associated antigen 1 (LFA-1), it is...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2721316/ https://ncbi.nlm.nih.gov/pubmed/19707339 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|